Identifying opportunities to improve management of autoimmune hepatitis: Evaluation of drug adherence and psychosocial factors

Journal of Hepatology

Volumn 57, Issue 6, 2012, Pages 1299-1304

  Sockalingam, Sanjeev ^a,b,c   Blank, Diana ^a,b,c   Abdelhamid, Nour ^d   Abbey, Susan E ^b,c   Hirschfield, Gideon M ^e  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY AT BUFFALO   (United States)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Adherence; Autoimmune hepatitis; Psychosocial

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ANXIETY DISORDER; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; AVOIDANCE BEHAVIOR; BILIRUBIN BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORRELATIONAL STUDY; DEPRESSION; DISEASE SEVERITY; DISTRESS SYNDROME; EXPERIENCES IN CLOSE RELATIONSHIP SCALE; GENERALIZED ANXIETY DISORDER 7; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT HEALTH QUESTIONNAIRE 9; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SELF REPORT; STEROID THERAPY; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADULT; AGED; ANXIETY; DEPRESSION; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MEDICATION ADHERENCE; MIDDLE AGED;

EID: 84869226346     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.07.032     Document Type: Article

References (35)

1. S.P. Mistilis Natural history of active chronic hepatitis. II. Pathology, pathogenesis and clinico-pathological correlation Aust Ann Med 17 1968 277 288
2. R.D. Soloway, W.H. Summerskill, A.H. Baggenstoss, M.G. Geall, G.L. Gitnick, and I.R. Elveback Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis Gastroenterology 63 1972 820 833
3. E.L. Krawitt Autoimmune hepatitis N Engl J Med 354 2006 54 66
4. M.P. Manns, A.J. Czaja, J.D. Gorham, E.L. Krawitt, G. Mieli-Vergani, and D. Vergani Diagnosis and management of autoimmune hepatitis Hepatology 51 2010 2193 2213
5. G.C. Cook, R. Mulligan, and S. Sherlock Controlled prospective trial of corticosteroid therapy in active chronic hepatitis QJM 40 1971 159 185
6. S. Kanzler, G. Gerken, H. Lohr, P.R. Galle, K.H. Meyer zum Buschenfelde, and A.W. Lohse Duration of immunosuppressive therapy in autoimmune hepatitis J Hepatol 34 2001 354 355
7. S. Kanzler, H. Lohr, G. Gerken, P.R. Galle, and A.W. Lohse Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience Z Gastroenterol 39 2001 339-341, 344-338
8. B. Hoeroldt, E. McFarlane, A. Dube, P. Basumani, M. Karajeh, and M.J. Campbell Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center Gastroenterology 140 2011 1980 1989
9. N. Kerkar, R.A. Annunziato, L. Foley, J. Schmeidler, C. Rumbo, and S. Emre Prospective analysis of nonadherence in autoimmune hepatitis: a common problem J Pediatr Gastroenterol Nutr 43 2006 629 634
10. P. Ciechanowski, M. Sullivan, M. Jensen, J. Romano, and H. Summers The relationship of attachment style to depression, catastrophizing and health care utilization in patients with chronic pain Pain 104 2003 627 637
11. W.N. Gray, L.A. Denson, R.N. Baldassano, and K.A. Hommel Treatment Adherence in Adolescents With Inflammatory Bowel Disease: The Collective Impact of Barriers to Adherence and Anxiety/Depressive Symptoms J Pediatr Psychol 2011
12. J.A. Butler, R.C. Peveler, P. Roderick, P.W. Smith, R. Horne, and J.C. Mason Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: a cross-sectional study Nephrol Dial Transplant 19 2004 3144 3149
13. S. Nahon, P. Lahmek, C. Saas, C. Durance, A. Olympie, and B. Lesgourgues Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: results of the ISSEO survey Inflamm Bowel Dis 17 2011 1270 1276
14. S. Lamba, R. Nagurka, K.K. Desai, S.J. Chun, B. Holland, and B. Koneru Self-reported non-adherence to immune-suppressant therapy in liver transplant recipients: demographic, interpersonal, and intrapersonal factors Clin Transplant 2011
15. P. Ciechanowski, J. Russo, W. Katon, M. Von Korff, E. Ludman, and E. Lin Influence of patient attachment style on self-care and outcomes in diabetes Psychosom Med 66 2004 720 728
16. P. Ciechanowski, J. Russo, W.J. Katon, E.H. Lin, E. Ludman, and S. Heckbert Relationship styles and mortality in patients with diabetes Diabetes Care 33 2010 539 544
17. S. Srivastava, and J.L. Boyer Psychological stress is associated with relapse in type 1 autoimmune hepatitis Liver Int 30 2010 1439 1447
18. G.R. Santos, I.F. Boin, M.I. Pereira, T.C. Bonato, R.C. Silva, and R.S. Stucchi Anxiety levels observed in candidates for liver transplantation Transplant Proc 42 2010 513 516
19. B.L. Svarstad, B.A. Chewning, B.L. Sleath, and C. Claesson The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence Patient Educ Couns 37 1999 113 124
20. S.R. Heckbert, C.M. Rutter, M. Oliver, L.H. Williams, P. Ciechanowski, and E.H. Lin Depression in relation to long-term control of glycemia, blood pressure, and lipids in patients with diabetes J Gen Intern Med 25 2010 524 529
21. N. Holzapfel, C. Zugck, T. Muller-Tasch, B. Lowe, and B. Wild Routine screening for depression and quality of life in outpatients with congestive heart failure Psychosomatics 48 2007 112 116
22. S. Sockalingam, D. Blank, A. Al Jarad, F. Alosaimi, G. Hirschfield, and S.E. Abbey A comparison of depression screening instruments in hepatitis C and the impact of depression on somatic symptoms Psychosomatics 52 2011 433 440
23. R.L. Spitzer, K. Kroenke, J.B. Williams, and B. Lowe A brief measure for assessing generalized anxiety disorder: the GAD-7 Arch Intern Med 166 2006 1092 1097
24. K. Kroenke, R.L. Spitzer, J.B. Williams, P.O. Monahan, and B. Lowe Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection Ann Intern Med 146 2007 317 325
25. C. Lo, A. Walsh, M. Mikulincer, L. Gagliese, C. Zimmermann, and G. Rodin Measuring attachment security in patients with advanced cancer: psychometric properties of a modified and brief Experiences in Close Relationships scale Psychooncology 18 2009 490 499
26. J. Bowlby Attachment and loss 1969 Basic Books New York
27. J.J. Hunter, and R.G. Maunder Using attachment theory to understand illness behavior Gen Hosp Psychiatry 23 2001 177 182
28. P.S. Ciechanowski, W.J. Katon, J.E. Russo, and E.A. Walker The patient-provider relationship: attachment theory and adherence to treatment in diabetes Am J Psychiatry 158 2001 29 35
29. Brennan KA, Clark CL, Shaver PR. Self-report measurement of adult attachment. In: Simpson JA, Rhodes WS, editors. New York: Guildford; 1988.
30. S. Gilbody, D. Richards, S. Brealey, and C. Hewitt Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis J Gen Intern Med 22 2007 1596 1602
31. W. Swardfager, N. Herrmann, S. Marzolini, M. Saleem, S.B. Farber, and A. Kiss Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery disease J Clin Psychiatry 72 2011 1181 1188
32. I.D. Kalsekar, S.S. Madhavan, M.M. Amonkar, E.H. Makela, V.G. Scott, and S.M. Douglas Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents Ann Pharmacother 40 2006 605 611
33. L.K. Bauer, M.A. Caro, S.R. Beach, C.A. Mastromauro, E. Lenihan, and J.L. Januzzi Effects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patients Am J Cardiol 2012
34. B. Lowe, I. Wahl, M. Rose, C. Spitzer, H. Glaesmer, and K. Wingenfeld A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population J Affect Disord 122 2010 86 95
35. J. Jin, G.E. Sklar, V. Min Sen Oh, and S. Chuen Li Factors affecting therapeutic compliance. A review from the patient's perspective Ther Clin Risk Manag 4 2008 269 286